XML 38 R28.htm IDEA: XBRL DOCUMENT

Cash and Marketable Securities (Tables)

3 Months Ended

Mar. 31, 2024

Cash and Cash Equivalents [Abstract]

Summary of Reconciliation of Cash and Cash Equivalents

A reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets to the amount reported within the condensed consolidated statements of cash flows is shown in the table below (in thousands):


	March 31, 2024		March 31, 2023
Cash and cash equivalents	$	93,299	$	74,660
Restricted cash	583		520
Total cash, cash equivalents and restricted cash at the end of the period	$	93,882	$	75,180

Summary of Marketable Securities

The amortized cost, gross unrealized holding gains and fair value of the Company’s marketable securities by major security type at each balance sheet date are summarized in the tables below (in thousands):


	March 31, 2024
	Amortized Cost		Unrealized Holding Gains, Net		Fair Value
Short-term marketable securities:
U.S. agency securities	$	79,603	$	640	$	80,243
Corporate debt securities	43,019		587		43,606
Total short-term marketable securities	$	122,622	$	1,227	$	123,849


	December 31, 2023
	Amortized Cost		Unrealized Holding Gains, Net		Fair Value
Short-term marketable securities:
U.S. agency securities	$	80,468	$	2,038	$	82,506
Corporate debt securities	72,753		711		73,464
Total short-term marketable securities	$	153,221	$	2,749	$	155,970